Skip to main content

Latest SEC Filings — Page 134

Most recent SEC EDGAR filings across all covered tickers, sorted chronologically. Wiseek AI reads each filing and scores it 1–10 for market-moving potential; click through for full analysis.

How Wiseek curates this list

Every filing on this page is sourced directly from SEC EDGAR, the U.S. Securities and Exchange Commission's public filings system. Wiseek processes 8-K, 10-K, 10-Q, Form 4, Form 144, DEF 14A, Schedule 13D/A and related disclosures filed by U.S.-listed companies. The original filing is always linked from each article so readers can verify the source document directly.

How filings get scored

Each filing runs through Wiseek's importance scorer, which weights filing type, deal magnitude, insider participation, material-event flags (going-concern, restatements, executive transitions, M&A) and historical market-reaction patterns. Filings scoring below 7 on the 1–10 scale are filtered out at the database query so this list stays focused on market-moving disclosures. See our methodology for the full rubric.

Editorial standards

Wiseek does not edit the underlying SEC filing. Plain-English summaries and key-event extractions are generated from the verified source text and clearly attributed as AI-generated. Wiseek does not provide investment advice — see our editorial policy for full standards on accuracy, source disclosure, and corrections.

Track by company

Follow all SEC filings for a specific company by visiting its ticker page: AAPL, MSFT, NVDA, TSLA, AMZN, GOOGL, META, JPM, V, UNH, XOM, AVGO, LLY, MA, COST, JNJ, PG, HD, ABBV, MRK, KO, NFLX, AMD, WMT, CVX, BAC — or browse all covered tickers.

IM Cannabis Signs Definitive Agreement to Sell European Assets to CEO-Controlled Entity
ProForm 6-KIMCC · Form 6-K · 2026-08-17
VYVGART Achieves Primary Endpoint in Phase 3 Myositis Trial for argenx
ProForm 6-KARGX · Form 6-K · 2026-08-17
DURAVYU Falls Short on Primary Endpoint in LUGANO, Yet Secondary Results Offer a Silver Lining
ProForm 8-KEYPT · Form 8-K · 2026-08-17
Lithium Americas Registers 72.6M Shares for Yorkville Resale, Reveals Conversion Terms and $15M Initial Conversion
ProForm S-3ASRLAC · Form S-3ASR · 2026-08-17
AMASS Brands Reports Q2 2026 Results and Issues First-Ever Guidance
Form 8-KAMSS · Form 8-K · 2026-08-17
NVIDIA and SB Energy Forge $105B AI Data Center Campus Partnership in Ohio
ProForm 8-KNVDA · Form 8-K · 2026-08-17
Corebridge Files Equitable Financials and Pro Forma Combined Statements for Pending Merger
Form 8-KCRBG · Form 8-K · 2026-08-17
CEO Or Offer Sells $6.3M in Shares After Exercising Options
ProForm 4SMWB · Form 4 · 2026-08-17
NOAA Publishes Notice of Intent for TMC's USA-B Exploration License EIS
Form 8-KTMC · Form 8-K · 2026-08-17
Dare Bioscience Details $6M Offering: Warrants, Fees, and Lock-Ups
Form 8-KDARE · Form 8-K · 2026-08-17
INVO Fertility Q2 Revenue Up 17%, Clinic Platform Turns Profitable
Form 8-KIVF · Form 8-K · 2026-08-17
Axe Compute Secures 55 MW AI Data Center Capacity in $500M+ Deal with Duos Technologies
ProForm 8-KAGPU · Form 8-K · 2026-08-17
Fulcrum-Slate Merger Details: 5% Ownership, $270M Special Dividend, Pipeline Revealed
ProForm 425FULC · Form 425 · 2026-08-17
HomeTrust to Acquire Blue Ridge Bankshares in $448M All-Stock Deal
ProForm 425HTB · Form 425 · 2026-08-17
Trinovium Partners with Echelon Data Centres to Develop AI Liquid Cooling
Form 6-KTRIB · Form 6-K · 2026-08-17
Fulcrum Therapeutics to Merge with Slate Medicines, Pivoting to Migraine Therapies with $245M Financing
ProForm 425FULC · Form 425 · 2026-08-17
HomeTrust to Acquire Blue Ridge Bankshares in $448M All-Stock Deal
ProForm 8-KHTB · Form 8-K · 2026-08-17
Dermata Secures $3.4M Private Placement with Insider Backing
ProForm 8-KDRMA · Form 8-K · 2026-08-17
Daré Bioscience Prices $6M Registered Direct Offering with Warrants at $1.37
ProForm 424B5DARE · Form 424B5 · 2026-08-17
Director Ryan Bond Buys $50K of Aclarion Stock at $2.37
Form 4ACON · Form 4 · 2026-08-17
Fulcrum to Merge with Slate Medicines in $350M All-Stock Deal, $245M PIPE
ProForm 8-KFULC · Form 8-K · 2026-08-17
NewGenIvf Exchanges $7.1M Convertible Notes, Sets $0.55 Conversion Price and Leak-Out Limits
ProForm 6-KNIVF · Form 6-K · 2026-08-17
Bitzero Q3 Loss Widens to $26.5M; Going Concern Doubt Raised
ProForm 6-KAIBZ · Form 6-K · 2026-08-17
Diana Shipping Withdraws $24.80/Share Offer for Genco After Board Demands $36.91/Share
ProForm SCHEDULE 13D/AGNK · Form SCHEDULE 13D/A · 2026-08-17
NexGel Q2 Revenue $3.69M, Net Loss $2.87M; Resolicits Shareholder Approval for Reverse Split
Form 8-KNXGL · Form 8-K · 2026-08-17
Vishal Garg Delivers Written Consents to Remove Five Directors, Threatens Consent Solicitation
ProForm SCHEDULE 13D/ABETR · Form SCHEDULE 13D/A · 2026-08-17
Sinovac H1 2026: Revenue Up 13%, Net Loss Widens to $60.2M; Rabies Vaccine Approved
Form 6-KSVA · Form 6-K · 2026-08-17
Serve Robotics Adds Grubhub Partnership, Expands to Two New Markets
Form 8-KSERV · Form 8-K · 2026-08-17
Teamshares Adds 16M-Share Primary Offering to Prospectus Amid Going Concern
ProForm 424B3TMS · Form 424B3 · 2026-08-17
American Water-Essential Utilities Merger Clears HSR Antitrust Review
Form 425AWK · Form 425 · 2026-08-17